diarrhea
second
lead
caus
death
children
year
global
parasit
genu
cryptosporidium
lead
caus
diarrhea
global
diseas
burden
attribut
cryptosporidiosi
substanti
approv
chemotherapeut
nitazoxanid
poor
efficaci
hiv
posit
children
chemotherapeut
develop
depend
calf
model
cryptosporidiosi
best
approxim
human
diseas
howev
model
consist
appli
across
research
studi
data
collect
commonli
occur
use
two
differ
method
complet
fecal
collect
cfc
requir
use
confin
hous
interv
collect
ic
permit
use
box
stall
cfc
mimic
human
challeng
model
methodolog
unknown
confin
hous
impact
studi
endpoint
data
gather
via
method
suitabl
gener
human
popul
use
modifi
crossov
studi
design
compar
cfc
ic
evalu
impact
hous
studi
endpoint
birth
calv
randomli
assign
confin
n
box
stall
hous
n
challeng
x
c
parvum
oocyst
follow
day
studi
endpoint
includ
fecal
oocyst
shed
sever
diarrhea
degre
dehydr
plasma
cortisol
calv
confin
signific
differ
mean
log
oocyst
enumer
per
gram
fecal
dri
matter
cfc
ic
sampl
p
diurnal
variat
oocyst
shed
p
confin
hous
calv
shed
significantli
plo
neglect
tropic
diseas
http
doi
cryptosporidium
genu
protozo
parasit
infect
wide
rang
host
includ
wild
domest
mammal
amphibian
reptil
pathogen
speci
c
homini
c
parvum
primarili
affect
peopl
cattl
respect
c
parvum
zoonot
repres
import
public
health
threat
resourcepoor
countri
particular
concern
children
live
close
proxim
cattl
resourcerich
countri
zoonosi
impact
agricultur
labor
commerci
dairi
farm
herd
preval
high
human
cattl
host
diseas
character
villu
atrophi
intestin
crypt
inflamm
malabsorpt
maldigest
diarrhea
may
secretori
natur
addit
larg
number
infect
oocyst
shed
stool
impact
environment
parasit
load
propag
fecalor
transmiss
diarrhea
identifi
lead
caus
death
children
yr
global
resourcepoor
countri
cryptosporidiosi
second
lead
caus
diarrhea
children
rotaviru
associ
increas
risk
death
first
yr
life
individu
immunocompromis
due
etiolog
hiv
sever
malnutrit
like
develop
lifethreaten
diarrhea
pediatr
cryptosporidiosi
also
associ
cognit
impair
stunt
regardless
develop
diarrhea
despit
advers
impact
human
live
treatment
vaccin
consist
effect
cryptosporidium
nitazoxanid
therapi
current
approv
treatment
cryptosporidiosi
peopl
demonstr
modest
efficaci
hivseroneg
children
hivseroposit
children
similarli
veterinari
patient
dearth
treatment
option
halofuginon
drug
licens
use
cattl
control
cryptosporidiosi
ideal
treatment
option
regist
countri
exclud
unit
state
effect
use
prophylact
therapeut
narrow
margin
safeti
costeffect
given
substanti
impact
cryptosporidiosi
child
health
resourcepoor
set
lack
option
prevent
treat
diseas
human
anim
popul
urgent
need
identifi
test
new
chemotherapeut
agent
develop
effect
chemotherapeut
repeat
reliabl
vivo
vitro
model
essenti
cryptosporidium
notori
difficult
cultur
studi
vitro
though
advanc
made
use
hollow
fiber
technolog
vivo
model
either
fail
achiev
compar
sever
clinic
ill
cumbersom
execut
murin
model
cryptosporidiosi
commonli
use
permit
induct
infect
c
parvum
although
c
parvum
hostadapt
mice
model
wide
appli
tractabl
cryptosporidium
speci
induc
sever
clinic
ill
mice
includ
c
muri
hostadapt
mice
studi
mous
model
report
weight
loss
listless
occasion
pasti
stool
report
fulmin
diarrhea
inabl
induc
measur
clinic
ill
major
limit
mous
model
must
abl
measur
respons
treatment
order
evalu
chemotherapeut
efficaci
calf
model
cryptosporidiosi
best
approxim
human
diseas
calv
experi
natur
infect
clinic
ill
mirror
human
symptomolog
howev
model
consist
appli
across
research
studi
may
impact
evalu
studi
endpoint
fecal
oocyst
shed
sever
diarrhea
degre
dehydr
type
hous
system
use
calf
model
studi
cryptosporidiosi
dictat
desir
method
fecal
sampl
two
method
commonli
use
collect
evalu
stool
calv
experiment
infect
c
parvum
complet
fecal
collect
cfc
method
interv
collect
ic
method
cfc
total
amount
stool
produc
calf
collect
everi
hour
blend
homogen
measur
either
weight
volum
aliquot
remov
evalu
interv
collect
method
small
fecal
sampl
g
collect
directli
rectum
calf
everi
everi
hour
histor
cryptosporidium
challeng
studi
conduct
human
volunt
use
cfc
human
particip
cfc
consid
goldstandard
evalu
reduct
diarrhea
respons
treatment
anoth
potenti
advantag
cfc
homogen
stool
sampl
prior
oocyst
enumer
mitig
risk
variat
oocyst
count
associ
intermitt
oocyst
shed
diurnal
fluctuat
though
report
possibl
diurnal
variat
oocyst
excret
confin
hous
clear
whether
would
issu
box
stall
hous
situat
confin
hous
major
disadvantag
cfc
cumbersom
difficult
execut
anim
model
human
volunt
varieti
sampl
collect
method
exist
permit
simpl
noninvas
collect
cfc
neonat
calv
collect
cfc
formid
challeng
requir
use
confin
hous
sever
restrict
calf
movement
abil
engag
natur
behavior
groom
calv
may
rise
lay
sternal
later
recumb
turn
around
ambul
use
degre
confin
necessari
order
direct
fecal
matter
expel
calf
directli
collect
pan
enlarg
confin
system
let
calf
ambul
allow
suffici
space
calf
turn
around
would
permit
collect
entir
stool
sampl
especi
peak
ill
calv
may
pass
stool
time
per
hour
hous
system
origin
develop
use
veal
industri
ideal
calf
welfar
may
accept
institut
anim
care
use
committe
particularli
european
institut
contrast
cfc
use
ic
method
allow
calv
hous
box
stall
move
freeli
also
ad
advantag
reduc
labor
requir
sampl
collect
calf
husbandri
addit
requir
use
confin
hous
implement
cfc
expens
maintain
labor
intens
age
restrict
calf
enrol
exceed
day
calv
older
day
larg
confin
hous
guid
care
use
agricultur
anim
research
teach
specif
state
calv
place
confin
day
life
thu
window
data
collect
confin
hous
limit
day
addit
limit
studi
effici
difficult
manag
larg
number
calv
typic
restrict
enrol
anim
also
risk
data
collect
period
may
repres
demonstr
calv
like
higher
level
cortisol
first
day
life
indic
higher
suscept
stress
howev
impact
confin
hous
cortisol
level
evalu
impact
elev
cortisol
studi
endpoint
also
assess
studi
conduct
compar
cfc
ic
studi
compar
confin
hous
box
stall
calf
model
cryptosporidiosi
substanti
knowledg
gap
consid
integr
model
cryptosporidium
drug
develop
unknown
ic
method
accept
altern
cfc
respect
relev
studi
endpoint
diarrheal
sever
magnitud
fecal
oocyst
shed
also
unknown
endpoint
impact
calf
confin
lastli
studi
compar
cortisol
level
neg
health
outcom
risk
calf
injuri
need
support
care
associ
hous
type
therefor
object
studi
determin
data
collect
via
ic
compar
data
collect
via
cfc
confin
hous
impact
studi
endpoint
use
evalu
chemotherapeut
agent
target
c
parvum
calf
model
studi
review
approv
washington
state
univers
institut
anim
care
use
committe
studi
adher
guidelin
put
forth
anim
welfar
act
specif
anim
welfar
act
regul
blue
book
usda
anim
total
holstein
bull
calv
enrol
contemporan
commerci
dairi
farm
locat
pasco
wa
calv
enrol
period
day
ensur
calv
expos
cryptosporidium
limit
exposur
microorgan
calv
attend
assist
perineum
dam
clean
thoroughli
povidoneiodin
scrub
calf
deliv
use
singleus
plastic
sheet
design
wheelbarrow
thoroughli
clean
disinfect
calv
physic
exam
conduct
calf
weigh
calv
normal
physic
exam
find
weigh
kg
enrol
upon
enrol
umbilicu
calf
dip
iodin
tinctur
ml
vitamin
e
selenium
bose
intervet
merck
anim
health
germani
administ
subcutan
calv
receiv
l
g
iggl
commerci
colostrum
replac
within
hour
birth
bovin
igg
colostrum
replac
land
olak
inc
st
paul
mn
via
esophag
tube
feeder
calv
transport
washington
state
univers
dedic
trailer
bed
steril
straw
anim
randomli
assign
box
stall
n
confin
hous
n
box
stall
neg
control
n
confin
hous
neg
control
n
treatment
hous
bsl
isol
facil
neg
control
calv
serv
sentinel
aid
monitor
inadvert
transmiss
parasit
calv
inadvert
transmiss
would
result
calv
receiv
larger
parasit
inoculum
other
could
impact
sever
clinic
ill
calv
box
stall
hous
individu
approxim
ft
space
bed
steril
wood
shave
mirror
place
eyelevel
environment
enrich
calv
confin
hous
group
place
insid
commerci
manufactur
elev
calf
stall
wenk
manufactur
pender
nebraska
provid
environment
enrich
stall
place
bsl
room
calv
face
toward
distanc
ft
prevent
crosscontamin
surfac
area
stall
ft
cm
long
cm
wide
stall
rais
cm
ground
fig
stall
construct
cm
galvan
squar
frame
tube
opengr
rubber
coat
floor
permit
fece
fall
stall
collect
bin
complianc
guid
care
use
agricultur
anim
research
teach
day
life
calv
random
confin
hous
remov
confin
place
box
stall
calv
follow
day
postinfect
cours
enrol
calv
fed
everi
h
via
nippl
bucket
commerci
nonmed
milk
replac
contain
crude
protein
fat
maxicar
land
olak
shoreview
mn
water
provid
ad
libitum
calv
randomli
assign
inocul
n
neg
control
group
n
calv
inocul
group
challeng
commerci
avail
iowa
laboratori
isol
cryptosporidium
parvum
within
h
birth
dose
oocyst
bunch
grass
farm
deari
id
oocyst
administ
within
month
origin
isol
clean
one
minut
sodium
hypochlorit
inactiv
possibl
virus
bacteria
copurifi
oocyst
wash
four
time
phosphat
buffer
salin
remov
sodium
hypochlorit
oocyst
deliv
oral
ml
suspens
via
rigid
oral
portion
esophag
feeder
follow
approxim
water
ensur
entir
oocyst
suspens
given
calf
neg
control
calv
sham
challeng
maintain
blind
calv
confin
hous
underw
cfc
everi
h
ic
sampl
collect
everi
h
calv
box
stall
ic
sampl
collect
everi
h
ic
sampl
g
stool
collect
directli
rectum
calf
via
digit
manipul
glove
hand
cfc
method
previous
describ
stool
collect
use
briefli
fecal
collect
pan
place
beneath
calf
urin
divert
h
adult
diaper
prevent
contamin
fecal
pan
stool
fecal
pan
collect
everi
h
blend
homogen
ensur
uniform
oocyst
distribut
content
blender
weigh
kg
homogen
g
aliquot
fece
remov
ic
cfc
sampl
enumer
via
realtim
quantit
polymeras
chain
reaction
qpcr
oocyst
count
interpol
qpcr
use
serial
dilut
commerci
purifi
c
parvum
oocyst
waterborn
inc
new
orlean
la
total
nucleic
acid
extract
supernat
mg
fecal
sampl
oocyst
suspens
neg
control
homogen
pb
use
magnet
bead
base
autom
procedur
appli
biosytem
foster
citi
ca
exogen
control
phage
ad
lysi
buffer
control
extract
effici
qpcr
cryptosporidium
spp
rrna
perform
use
previous
describ
assay
appli
biosystem
placfcrm
use
inhibitoroptim
master
mix
part
quantabio
beverli
nm
forward
primer
nm
revers
primer
nm
probe
label
fam
cfc
ic
sampl
count
standard
fecal
dri
weight
percentag
dri
weight
analysi
fecal
sampl
obtain
take
g
portion
origin
fecal
sampl
dri
minimum
h
squaroid
vaccuum
oven
lablin
kochi
india
weigh
directli
scout
pro
ohau
corpor
pine
brook
nj
calv
examin
evalu
everi
h
complet
physic
exam
conduct
everi
h
feed
time
time
physic
exam
new
injuri
clinic
sign
document
includ
abras
wound
well
swell
area
local
pain
fever
order
minim
interobserv
bia
standard
valid
rubric
use
previous
describ
addit
research
personnel
underw
train
maxim
interobserv
agreement
appetit
fecal
consist
mentat
state
mental
activ
respons
hydrat
statu
individu
evalu
ordin
scale
score
repres
normal
clinic
find
score
consist
sever
clinic
ill
specifi
categori
tabl
qualit
measur
hydrat
skin
turgor
degre
enophthalmo
use
monitor
enophthalmo
necessari
identifi
calv
risk
develop
corneal
ulcer
sever
dehydr
worsen
calv
globe
eye
reced
orbit
eyelid
roll
inward
caus
eyelash
rest
directli
cornea
abrad
surfac
hydrat
statu
also
assess
quantit
via
measur
urin
product
everi
h
determin
urin
product
without
use
urinari
cathet
adult
diaper
weigh
secur
calf
peni
reweigh
determin
differ
kg
blood
sampl
collect
via
jugular
venipunctur
day
postinfect
sampl
collect
sampl
obtain
individu
train
blood
collect
use
vacutain
system
enrol
calv
reduc
risk
fals
elev
cortisol
level
effort
made
creat
excess
stress
prior
blood
collect
eg
loud
nois
chang
light
use
excess
restraint
venipunctur
attempt
calv
confin
hous
alreadi
restrain
within
hous
system
addit
restraint
anim
requir
could
result
addit
stress
blood
collect
calv
confin
hous
reach
directli
bar
hous
mechan
calv
box
stall
restrain
sternal
recumb
visual
jugular
vein
restraint
less
sec
attempt
made
avoid
chase
calv
captur
stall
howev
calv
box
stall
gener
energet
therefor
ambul
frequent
prior
blood
collect
cortisol
extract
calf
plasma
solid
phase
extract
quantifi
use
ultra
perform
liquid
chromatographi
tandem
mass
spectrometri
uplcmsm
cortisol
cortisold
purchas
cerilli
round
rock
tx
stock
solut
separ
prepar
methanol
concentr
ng
ml
respect
calibr
curv
gener
calf
plasma
nomin
concentr
ngml
qualiti
control
qc
sampl
prepar
nomin
concentr
ngml
calibr
qc
sampl
ad
plate
along
studi
sampl
next
cortisold
solut
ad
well
follow
addit
methanol
sampl
aspir
centrifug
rcf
minut
follow
centrifug
result
supernat
remov
place
well
plate
phosphor
acid
ad
aliquot
sampl
mix
thoroughli
sampl
place
oasi
prime
hlb
plate
water
milford
wash
aliquot
methanol
next
aliquot
acetonitril
methanol
ad
sampl
result
eluat
dilut
water
sampl
inject
onto
acquiti
uplc
tandem
water
xevo
tq
zorbax
eclips
plu
column
agil
santa
clara
ca
heat
mobil
phase
water
formic
acid
b
acetonitril
formic
acid
use
follow
gradient
first
minut
minut
decreas
minut
follow
increas
back
minut
flow
rate
solvent
mlmin
transit
mz
use
quantifi
cortisol
cortisold
respect
endogen
cortisol
observ
calf
serum
use
gener
calibr
curv
amount
natur
occur
cortisol
subtract
calibr
curv
qc
sampl
qc
sampl
within
expect
valu
coeffici
variat
cv
descript
inferenti
method
use
shapirowilk
test
use
determin
data
nongaussian
hypothesi
test
normal
distribut
continu
data
analyz
use
student
test
analysi
varianc
categor
variabl
test
via
chisquar
fisher
exact
nonnorm
continu
variabl
either
logtransform
analyz
via
wilcoxon
rank
sum
test
wilcoxon
rank
sum
use
assess
differ
fecal
oocyst
count
fecal
dri
matter
percentag
ic
cfc
sampl
confin
hous
calv
ic
sampl
confin
hous
box
stall
calv
wilcoxon
rank
sum
test
also
use
evalu
differ
plasma
cortisol
daili
weight
gain
daili
milk
replac
consumpt
volum
fluid
therapi
frequenc
nonfluid
therapi
treatment
confin
hous
box
stall
calv
chisquar
fisher
exact
test
use
describ
associ
frequenc
injuri
hous
type
frequenc
injuri
count
time
diagnosi
frequenc
nonfluid
therapi
treatment
count
everi
intervent
follow
diagnosi
frequenc
injuri
nonfluid
therapi
treatment
record
manner
enabl
abil
track
occurr
new
injuri
well
assess
amount
research
effort
requir
subsequ
treat
manag
injuri
bivari
analysi
use
evalu
relationship
log
oocyst
per
gram
fecal
dri
matter
plasma
cortisol
order
identifi
best
predictor
total
fecal
output
simpl
backward
stepwis
regress
carri
achiev
parsimoni
model
individu
explanatori
variabl
pvalu
bivari
analysi
retain
data
analyz
use
jmp
pro
sa
institut
inc
cari
nc
enrol
calv
weigh
averag
kg
birth
rang
kg
mean
serum
total
protein
measur
h
life
gdl
rang
gdl
differ
serum
total
protein
across
group
p
calv
experienc
failur
passiv
transfer
calv
challeng
c
parvum
oocyst
develop
fecal
oocyst
shed
within
day
postinfect
pi
day
pi
day
pi
day
pi
median
durat
parasit
challeng
onset
fulmin
diarrhea
clinic
ill
consist
cryptosporidiosi
day
postinfect
day
pi
calv
still
shed
oocyst
stool
stool
test
via
qpcr
coinfect
enrol
calv
neg
e
coli
k
salmonella
spp
rotaviru
corona
viru
two
neg
control
calv
develop
cryptosporidiosi
order
prevent
calv
turn
around
stall
urin
fecal
collect
bin
appli
headcatch
anim
calv
die
becam
cast
stall
unabl
rise
anim
remov
studi
final
analysi
includ
confin
hous
calv
calv
hous
confin
hous
n
mean
total
fecal
output
kgday
rang
kgday
mean
total
urin
output
kgday
rang
kgday
day
studi
period
tabl
uninfect
control
calf
confin
hous
mean
total
fecal
output
kgday
rang
kgday
total
mean
urin
output
kgday
rang
kgday
tabl
day
period
confin
signific
differ
mean
log
oocyst
enumer
per
gram
fecal
dri
matter
cfc
ic
sampl
p
diurnal
variat
oocyst
shed
morn
even
ic
fecal
sampl
p
fig
fecal
dri
matter
percent
significantli
lower
cfc
sampl
p
tabl
tabl
descript
summari
daili
stool
urin
product
calv
n
confin
hous
day
postinfect
stool
productionday
kg
mean
sd
urin
productionday
kg
mean
sd
iqr
fecal
dri
matter
percentageday
mean
sd
compar
across
calv
confin
hous
n
calv
box
stall
n
calv
confin
hous
shed
significantli
oocyst
stool
p
fig
mean
peak
oocyst
shed
confin
hous
calv
log
oocyst
gram
fecal
dri
matter
nearli
order
magnitud
greater
mean
peak
box
stall
calv
fecal
dri
matter
percentag
significantli
lower
cfc
sampl
confin
hous
calv
compar
ic
sampl
box
stall
calv
p
howev
signific
differ
p
fecal
dri
matter
percentag
ic
sampl
collect
confin
hous
box
stall
calv
tabl
day
postinfect
calv
confin
hous
experienc
significantli
sever
clinic
outcom
comparison
box
stall
calv
across
studi
endpoint
except
averag
daili
weight
gain
even
though
calv
confin
hous
consum
less
milk
replac
p
tabl
calv
confin
hous
requir
significantli
fluid
therapi
maintain
hydrat
statu
day
period
confin
p
remov
confin
place
box
stall
p
tabl
fig
averag
day
postinfect
confin
hous
calv
requir
lday
parenter
oral
fluid
therapi
box
stall
calv
requir
lday
tabl
calv
confin
hous
also
like
becom
injur
frequenc
abras
lacer
significantli
greater
p
confin
hous
calv
frequenc
pressur
sore
p
tabl
confin
impact
confin
hous
calf
model
cryptosporidiosi
hous
calv
receiv
significantli
nonfluid
therapi
support
care
p
form
administ
pain
medic
topic
eye
skin
treatment
wound
care
bandag
chang
plasma
cortisol
sampl
infect
confin
hous
calv
n
box
stall
calv
n
evalu
day
postinfect
distribut
plasma
cortisol
log
oocyst
per
gram
fecal
dri
matter
plot
outlier
confin
hous
group
identifi
remov
analysi
first
measur
plasma
cortisol
valu
calv
greater
ngml
test
limit
calv
confin
calv
box
stall
due
sampl
loss
mean
plasma
cortisol
level
significantli
higher
confin
hous
calv
ngml
box
stall
calv
ngml
p
fig
mean
plasma
cortisol
level
increas
mean
log
oocyst
per
gram
fecal
dri
matter
significantli
increas
p
fig
tabl
everi
point
increas
plasma
cortisol
log
increas
oocyst
shed
fig
hous
group
initi
similar
plasma
cortisol
level
tabl
descript
summari
studi
endpoint
calv
confin
hous
n
box
stall
n
day
postinfect
tabl
descript
summari
support
care
administ
calv
confin
hous
n
box
stall
n
daili
determin
best
predictor
total
fecal
output
backward
stepwis
regress
carri
follow
explanatori
variabl
enter
model
plasma
cortisol
percent
milk
replac
consum
log
oocyst
per
gram
fecal
dri
matter
fecal
dri
matter
percentag
also
includ
interact
log
oocyst
per
gram
fecal
dri
matter
plasma
cortisol
log
oocyst
per
gram
fecal
dri
matter
fecal
dri
matter
percentag
interact
term
found
nonsignific
remov
model
remain
variabl
retain
log
oocyst
per
gram
fecal
dri
matter
found
nonsignific
p
remov
best
predictor
total
fecal
output
plasma
cortisol
p
percent
milk
replac
consum
p
fecal
dri
matter
percentag
p
tabl
recent
larg
multicent
studi
investig
etiolog
diarrhea
children
demonstr
cryptosporidium
spp
one
main
pathogen
contribut
global
burden
pediatr
diarrhea
yet
vaccin
prevent
infect
licens
drug
treatment
poor
efficaci
effort
acceler
identif
lead
drug
candid
gener
increas
demand
calf
model
cryptosporidiosi
surg
demand
underscor
need
critic
evalu
refin
calf
model
cryptosporidiosi
order
garner
best
data
possibl
applic
veterinari
medicin
translat
human
patient
alarmingli
model
frequent
appli
inconsist
model
execut
come
light
one
pronounc
inconsist
pertain
use
confin
hous
research
calv
desir
mimic
human
challeng
studi
collect
total
fecal
output
research
calv
necessit
use
confin
hous
use
confin
hous
conflict
five
freedom
anim
commonli
use
defin
paramet
anim
welfar
determin
anim
hous
environ
handl
adequ
case
confin
hous
freedom
express
natur
behavior
observ
research
set
five
freedom
may
compromis
scientif
justif
accept
altern
exist
date
one
evalu
confin
hous
sidebysid
box
stall
hous
determin
box
stall
hous
accept
altern
calf
model
cryptosporidiosi
studi
demonstr
use
confin
hous
unnecessari
measur
studi
endpoint
total
oocyst
excret
diarrhea
quantiti
qualiti
moreov
use
confin
hous
appear
stress
calv
lead
increas
oocyst
excret
may
confound
data
underestim
efficaci
chemotherapeut
studi
impact
confin
hous
calf
model
cryptosporidiosi
find
challeng
assumpt
cfc
requir
get
accur
measur
oocyst
excret
quantiti
qualiti
diarrhea
first
find
differ
log
fecal
oocyst
enumer
per
gram
fecal
dri
matter
cfc
ic
sampl
among
calv
confin
previous
thought
homogen
cfc
sampl
would
result
accur
oocyst
enumer
support
data
contrari
greater
variat
oocyst
enumer
cfc
sampl
evidenc
larger
standard
error
bar
fig
sinc
count
standard
fecal
dri
matter
percentag
would
indic
differ
attribut
increas
water
content
stool
sampl
also
suggest
cfc
must
collect
homogen
due
possibl
diurnal
variat
fecal
oocyst
shed
observ
signific
differ
number
oocyst
enumer
sampl
collect
morn
even
import
note
cfc
permit
captur
total
fecal
output
entir
cfc
sampl
analyz
cfc
ic
mg
aliquot
stool
homogen
equal
amount
pb
qpcr
perform
oocyst
count
standard
fecal
dri
matter
percentag
therefor
find
indic
repres
stool
sampl
attain
via
ic
collect
total
fecal
output
necessari
order
attain
repres
stool
sampl
oocyst
enumer
via
qpcr
fecal
dri
matter
percentag
significantli
lower
cfc
sampl
compar
ic
collect
calv
confin
control
oocyst
enumer
standard
fecal
dri
matter
percentag
increas
water
content
cfc
sampl
could
sever
diarrhea
improv
abil
measur
water
content
due
sampl
homogen
altern
could
due
urin
contamin
fecal
bin
previous
describ
increas
urin
product
secondari
increas
frequenc
fluid
therapi
although
adult
diaper
secur
calv
use
duct
tape
st
paul
mn
elastikon
johnson
johnson
new
brunswick
nj
diaper
slide
place
calf
movement
expos
peni
addit
first
day
confin
calv
small
enough
turn
around
stall
thu
instanc
defec
urin
bin
would
fals
lower
fecal
dri
matter
percentag
stool
collect
fecal
bin
fals
elev
volum
urin
collect
fig
lower
fecal
dri
matter
percentag
detect
confin
hous
calv
true
find
indic
cfc
better
detect
increas
water
content
stool
would
indic
confin
exacerb
sever
diarrhea
possibl
given
calv
confin
hous
requir
significantli
support
care
calv
box
stall
calv
confin
hous
receiv
averag
l
fluid
therapi
day
compar
box
stall
calv
receiv
lday
thu
confin
hous
calv
may
experi
greater
volum
fluid
elimin
due
greater
volum
fluid
support
howev
compar
ic
sampl
confin
hous
calv
ic
sampl
box
stall
calv
signific
differ
fecal
dri
matter
percentag
thu
probabl
differ
fecal
dri
matter
percentag
cfc
ic
sampl
confin
hous
calv
least
partial
attribut
urin
contamin
fecal
bin
calv
confin
hous
shed
significantli
oocyst
stool
peak
shed
differ
order
magnitud
greater
confin
hous
calv
sinc
differ
shed
detect
ic
cfc
sampl
confin
hous
calv
stand
reason
differ
shed
detect
box
stall
confin
hous
calv
true
effect
moreov
sinc
qpcr
data
standard
fecal
dri
matter
percentag
data
suscept
dilut
effect
increas
water
content
stool
sampl
possibl
differ
fecal
oocyst
shed
explain
signific
differ
plasma
cortisol
concentr
confin
hous
box
stall
calv
healthi
calv
plasma
cortisol
concentr
report
high
birth
ngml
gradual
decreas
first
day
life
ngml
consist
find
box
stall
calv
calv
confin
hous
impact
confin
hous
calf
model
cryptosporidiosi
follow
pattern
plasma
cortisol
elev
day
postinfect
ngml
confin
hous
calv
coincid
observ
peak
fecal
oocyst
shed
thu
feasibl
increas
stress
due
confin
exacerb
degre
fecal
oocyst
shed
confin
hous
calv
conclus
support
bivari
analysi
plasma
cortisol
level
log
oocyst
per
gram
fecal
dri
matter
significantli
associ
could
argu
confin
hous
effect
creat
immunosuppress
calf
model
cryptosporidiosi
may
deem
desir
cryptosporidium
research
mani
children
infect
cryptosporidium
immunocompromis
due
comorbid
howev
unlik
immun
suppress
mous
model
diminish
immun
function
intent
induc
presum
reduct
immun
function
due
hypercortisolemia
calv
confin
hous
patholog
state
chemotherapeut
efficaci
face
immunocompromis
desir
test
chemotherapeut
anim
model
degre
immun
suppress
induc
must
predict
repeat
find
also
indic
calv
confin
hous
substanti
physic
metabol
decompens
calv
box
stall
confin
hous
calv
requir
fluid
therapi
ate
significantli
less
milk
replac
reduc
milk
replac
consumpt
indic
reduc
calf
wellb
calf
model
cryptosporidiosi
addit
relev
failur
meet
daili
fluid
requir
consumpt
milk
replac
put
calv
greater
risk
sever
dehydr
develop
metabol
acidosi
result
calf
death
remov
studi
confin
hous
calv
also
receiv
significantli
nonfluid
treatment
indic
reduc
calf
welfar
also
indic
increas
time
demand
studi
personnel
provis
care
sick
calv
box
stall
calv
experienc
abras
lacer
pressur
sore
type
injuri
occur
confin
hous
calv
like
injur
metal
framework
calf
stall
lack
shock
absorpt
lie
predispos
calv
repeat
injuri
joint
boni
promin
sever
durat
injuri
may
impact
elev
plasma
cortisol
level
mice
place
confin
induc
repeat
restraint
stress
experienc
impair
wound
heal
partial
stressinduc
glucocorticoid
releas
given
find
want
determin
variabl
could
collect
without
use
confin
hous
would
accur
predict
total
fecal
output
produc
calf
experiment
infect
c
parvum
regress
model
hold
variabl
constant
plasma
cortisol
percent
milk
replac
consum
fecal
dri
matter
percentag
ic
sampl
best
predictor
total
fecal
output
measur
via
cfc
variabl
account
greatest
amount
intercalf
variat
total
fecal
output
indic
use
combin
studi
endpoint
better
measur
treatment
effect
total
fecal
output
alon
regress
model
also
suggest
total
fecal
output
sensit
hypercortisolemia
interestingli
log
oocyst
per
gram
fecal
dri
matter
good
predictor
total
fecal
output
previou
studi
shown
magnitud
oocyst
shed
track
ordin
measur
sever
diarrhea
consid
alongsid
data
indic
ordin
measur
sever
diarrhea
total
fecal
output
synonym
fecal
dri
matter
percentag
better
proxi
measur
total
fecal
output
find
studi
suggest
confin
hous
calv
may
affect
studi
endpoint
import
evalu
novel
chemotherapeut
target
cryptosporidium
fecal
oocyst
shed
appetit
frequenc
fluid
therapi
studi
endpoint
significantli
impact
use
confin
hous
result
indic
repres
data
captur
via
ic
calv
hous
box
stall
data
less
like
impact
immunomodulatori
effect
stress
hypercortisolemia
collect
total
fecal
output
mirror
methodolog
use
human
challeng
studi
use
confin
captur
total
fecal
output
confound
data
use
assess
studi
endpoint
reduc
overal
compar
human
challeng
model
given
confin
hous
calv
experi
increas
sever
ill
higher
plasma
cortisol
level
greater
risk
injuri
higher
requir
fluid
therapi
use
confin
hous
evalu
novel
chemotherapeut
target
cryptosporidium
spp
may
result
reduc
abil
detect
treatment
effect
said
studi
limit
fact
compar
outcom
two
hous
system
trial
actual
cryptosporidium
therapeut
howev
box
stall
hous
recent
use
success
trial
evalu
novel
drug
target
cryptosporidium
studi
also
subject
potenti
bia
due
inabl
blind
observ
hous
system
reason
report
evalu
subject
observ
assess
studi
mentat
assess
restrict
use
determin
need
support
care
reduc
risk
bia
evalu
injuri
sever
assess
instead
assess
injuri
abras
pressur
sore
dichotom
present
present
blind
maintain
laboratori
analysi
stool
blood
sampl
abl
report
associ
plasma
cortisol
oocyst
shed
studi
design
assess
stress
primari
endpoint
cortisol
one
marker
stress
complet
assess
stress
includ
behavior
assess
marker
substanc
p
would
aid
interpret
data
anoth
concern
loss
calv
confin
group
due
death
could
result
imprecis
estim
howev
feel
imprecis
estim
minor
concern
rel
major
concern
compromis
research
anim
welfar
consid
togeth
risk
imprecis
measur
due
loss
well
reduc
welfar
result
death
injuri
substanti
need
revis
method
use
studi
cryptosporidiosi
calf
model
lastli
studi
author
extens
experi
use
box
stall
first
studi
use
confin
hous
could
argu
experienc
hand
studi
find
may
differ
address
consult
research
current
execut
studi
confin
follow
protocol
ident
previous
publish
conclus
opinion
box
stall
hous
preferenti
use
calf
model
cryptosporidiosi
confin
hous
compromis
calf
welfar
alter
import
outcom
appear
stress
calv
lead
sicker
heavili
infect
calv
support
inform
tabl
rubric
evalu
appetit
mentat
fecal
consist
hydrat
